Internal Medicine, Endocrinology, Diabetes, & Metabolism · Garland, TX
NPI
1609805506
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
601 Clara Barton Blvd, Suite 300
Garland, TX, 75042
Phone (972) 494-6235
Groups this clinician bills Medicare through
Medicare paid, 2024
$15K
215 services
Medicare patients, 2024
90
Average age 74
Drug cost, 2024
$1.3M
2,203 prescriptions
Company payments, 2025
$3,855
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Qing Jia was code 99214 (office e&m - established), 56 times for 50 patients. In total Qing Jia billed 215 services in 22 codes, and Medicare paid $15K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 56 | 50 | $94.78 | $5,308 |
| 95251 Test - Miscellaneous | Office | 38 | 35 | $25.71 | $977 |
| 99213 Office E&M - Established | Office | 33 | 26 | $67.07 | $2,213 |
| 76536 Ultrasound - Nonspecific | Office | 15 | 15 | $82.42 | $1,236 |
| 99204 Office E&M - New | Office | 15 | 15 | $127.46 | $1,912 |
| 82947 Clinical Chemistry | Office | 14 | 14 | $3.85 | $53.9 |
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 14 | 14 | $3.85 | $53.9 |
Medicare prescription drug claims, 2024
In 2024, the drug Qing Jia prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 183 prescriptions and refills. In total Qing Jia wrote 2,203 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Synthroid Levothyroxine Sodium | 183 | 415 | 51 | $18K |
| Ozempic Semaglutide | 146 | 219 | 32 | $206K |
| Mounjaro Tirzepatide | 110 | 160 | 25 | $169K |
| Glimepiride Generic | 99 | 183 | 29 | $682 |
| Levothyroxine Sodium Generic | 82 | 172 | 29 | $763 |
| Metformin Hcl Generic | 67 | 172 | 22 | $762 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 60 | 108 | 21 | $5,038 |
| Rybelsus Semaglutide | 58 | 80 | 14 | $76K |
| Farxiga Dapagliflozin Propanediol | 58 | 130 | 14 | $71K |
| Atorvastatin Calcium Generic | 56 | 146 | 18 | $611 |
| Kerendia Finerenone | 50 | 92 | Under 11 | $59K |
| Cequr Simplicity Bolus Insulin Pump, 200 Unit | 48 | 76 | 15 | $33K |
| Afrezza Insulin Regular, Human | 47 | 57 | Under 11 | $74K |
| Tresiba Flextouch U-100 Insulin Degludec | 47 | 88 | 13 | $22K |
| Trulicity Dulaglutide | 46 | 84 | 13 | $83K |
Brand drugs: 1,303 claims; generic drugs: 727 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Qing Jia $3,855 ($3,855 in general payments such as food, travel and fees) from 29 companies. The largest payer was Novo Nordisk Inc with $470.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 20 | $470 |
| Mannkind Corporation MNKD | 24 | $407 |
| Sequel Med Tech, LLC | 12 | $354 |
| Xeris Pharmaceuticals, Inc. | 12 | $223 |
| Tandem Diabetes Care, Inc. TNDM | 6 | $211 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 19 | $193 |
| Lilly USA, LLC LLY | 15 | $176 |
| Astellas Pharma US Inc 4503.T | 4 | $175 |
| Abbvie Inc. ABBV | 10 | $174 |
| IBSA Pharma Inc. | 9 | $170 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.